REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Sep 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-09-13

Reporting Person: Tessier-Lavigne Marc (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-13	Common Stock	M	4250	$273.67	Acquired	6328	Direct
2021-09-13	Common Stock	M	4250	$273.67	Acquired	10578	Direct
2021-09-13	Common Stock	M	4250	$273.67	Acquired	14828	Direct
2021-09-13	Common Stock	S	816	$636.64	Disposed	14012	Direct
2021-09-13	Common Stock	S	816	$637.71	Disposed	13196	Direct
2021-09-13	Common Stock	S	2098	$638.46	Disposed	11098	Direct
2021-09-13	Common Stock	S	1260	$639.45	Disposed	9838	Direct
2021-09-13	Common Stock	S	981	$640.61	Disposed	8857	Direct
2021-09-13	Common Stock	S	952	$641.56	Disposed	7905	Direct
2021-09-13	Common Stock	S	1645	$642.54	Disposed	6260	Direct
2021-09-13	Common Stock	S	1549	$643.33	Disposed	4711	Direct
2021-09-13	Common Stock	S	844	$644.52	Disposed	3867	Direct
2021-09-13	Common Stock	S	61	$645.21	Disposed	3806	Direct
2021-09-13	Common Stock	S	354	$646.24	Disposed	3452	Direct
2021-09-13	Common Stock	S	425	$647.39	Disposed	3027	Direct
2021-09-13	Common Stock	S	381	$648.25	Disposed	2646	Direct
2021-09-13	Common Stock	S	124	$649.35	Disposed	2522	Direct
2021-09-13	Common Stock	S	56	$650.33	Disposed	2466	Direct
2021-09-13	Common Stock	S	249	$651.54	Disposed	2217	Direct
2021-09-13	Common Stock	S	139	$652.26	Disposed	2078	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-13	Non-Qualified Stock Option (right to buy)	$273.67	M	4250	Disposed	2024-01-02	Common Stock (4250)	Direct
2021-09-13	Non-Qualified Stock Option (right to buy)	$273.67	M	4250	Disposed	2024-01-02	Common Stock (4250)	Direct
2021-09-13	Non-Qualified Stock Option (right to buy)	$273.67	M	4250	Disposed	2024-01-02	Common Stock (4250)	Direct

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: Represents volume-weighted average price of sales of 816 shares of Company stock on September 13, 2021 at prices ranging from $636.08 to $636.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F3: Represents volume-weighted average price of sales of 816 shares of Company stock on September 13, 2021 at prices ranging from $637.26 to $637.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 2,098 shares of Company stock on September 13, 2021 at prices ranging from $638.00 to $638.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 1,260 shares of Company stock on September 13, 2021 at prices ranging from $639.00 to $639.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 981 shares of Company stock on September 13, 2021 at prices ranging from $640.18 to $640.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 952 shares of Company stock on September 13, 2021 at prices ranging from $641.01 to $641.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 1,645 shares of Company stock on September 13, 2021 at prices ranging from $642.00 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 1,549 shares of Company stock on September 13, 2021 at prices ranging from $643.01 to $643.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 844 shares of Company stock on September 13, 2021 at prices ranging from $644.03 to $644.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F11: Represents volume-weighted average price of sales of 61 shares of Company stock on September 13, 2021 at prices ranging from $645.21 to $645.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F12: Represents volume-weighted average price of sales of 354 shares of Company stock on September 13, 2021 at prices ranging from $646.04 to $646.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F13: Represents volume-weighted average price of sales of 425 shares of Company stock on September 13, 2021 at prices ranging from $647.06 to $647.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F14: Represents volume-weighted average price of sales of 381 shares of Company stock on September 13, 2021 at prices ranging from $648.06 to $648.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F15: Represents volume-weighted average price of sales of 124 shares of Company stock on September 13, 2021 at prices ranging from $649.27 to $649.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F16: Represents volume-weighted average price of sales of 249 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

F17: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.